Follow
Tiziano Marzo
Tiziano Marzo
Dept. of Pharmacy, University of Pisa
Verified email at unipi.it
Title
Cited by
Cited by
Year
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study
T Marzo, D Cirri, C Gabbiani, T Gamberi, F Magherini, A Pratesi, A Guerri, ...
ACS medicinal chemistry letters 8 (10), 997-1001, 2017
1022017
Iridium (I) compounds as prospective anticancer agents: solution chemistry, antiproliferative profiles and protein interactions for a series of iridium (I) N‐heterocyclic …
Y Gothe, T Marzo, L Messori, N Metzler‐Nolte
Chemistry–A European Journal 22 (35), 12487-12494, 2016
792016
Biological applications of thiocarbohydrazones and their metal complexes: A perspective review
C Bonaccorso, T Marzo, D La Mendola
Pharmaceuticals 13 (1), 4, 2019
782019
Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections
MI Cassetta, T Marzo, S Fallani, A Novelli, L Messori
Biometals 27, 787-791, 2014
742014
The combined activation of KCa3. 1 and inhibition of Kv11. 1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells
S Pillozzi, M D'Amico, G Bartoli, L Gasparoli, G Petroni, O Crociani, ...
British journal of cancer 118 (2), 200-212, 2018
722018
Protein metalation by anticancer metallodrugs: a joint ESI MS and XRD investigative strategy
A Merlino, T Marzo, L Messori
Chemistry–A European Journal 23 (29), 6942-6947, 2017
722017
Replacement of the thiosugar of auranofin with iodide enhances the anticancer potency in a mouse model of ovarian cancer
T Marzo, L Massai, A Pratesi, M Stefanini, D Cirri, F Magherini, M Becatti, ...
ACS Medicinal Chemistry Letters 10 (4), 656-660, 2019
662019
Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs
D Cirri, A Pratesi, T Marzo, L Messori
Expert opinion on drug discovery 16 (1), 39-46, 2021
652021
Auranofin and its Analogues Show Potent Antimicrobial Activity against Multidrug‐Resistant Pathogens: Structure–Activity Relationships
T Marzo, D Cirri, S Pollini, M Prato, S Fallani, MI Cassetta, A Novelli, ...
ChemMedChem 13 (22), 2448-2454, 2018
642018
Unusual structural features in the lysozyme derivative of the tetrakis (acetato) chloridodiruthenium (II, III) complex
L Messori, T Marzo, RNF Sanches, D de Oliveira Silva, A Merlino
Angewandte Chemie International Edition 53 (24), 6172-6175, 2014
642014
A role for metal-based drugs in fighting COVID-19 infection? The case of auranofin
T Marzo, L Messori
ACS Medicinal Chemistry Letters 11 (6), 1067-1068, 2020
602020
Antiproliferative effects of two gold (I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study
F Magherini, T Fiaschi, E Valocchia, M Becatti, A Pratesi, T Marzo, ...
Oncotarget 9 (46), 28042, 2018
582018
Peculiar Features in the Crystal Structure of the Adduct Formed between cis-PtI2(NH3)2 and Hen Egg White Lysozyme
L Messori, T Marzo, C Gabbiani, AA Valdes, AG Quiroga, A Merlino
Inorganic Chemistry 52 (24), 13827-13829, 2013
582013
Oxaliplatin vs. cisplatin: Competition experiments on their binding to lysozyme
D Marasco, L Messori, T Marzo, A Merlino
Dalton transactions 44 (22), 10392-10398, 2015
562015
Interaction of anticancer Ru (III) complexes with single stranded and duplex DNA model systems
D Musumeci, L Rozza, A Merlino, L Paduano, T Marzo, L Massai, ...
Dalton Transactions 44 (31), 13914-13925, 2015
522015
cis-PtI 2 (NH 3) 2: a Reappraisal
T Marzo, S Pillozzi, O Hrabina, J Kasparkova, V Brabec, A Arcangeli, ...
Dalton Transactions, 2015
512015
Interactions of carboplatin and oxaliplatin with proteins: Insights from X-ray structures and mass spectrometry studies of their ribonuclease A adducts
L Messori, T Marzo, A Merlino
Journal of inorganic biochemistry 153, 136-142, 2015
502015
Arsenoplatin-1 is a dual pharmacophore anticancer agent
Đ Miodragović, A Merlino, EP Swindell, A Bogachkov, RW Ahn, ...
Journal of the American Chemical Society 141 (16), 6453-6457, 2019
492019
Cytotoxic activity and protein binding through an unusual oxidative mechanism by an iridium (i)–NHC complex
Y Gothe, T Marzo, L Messori, N Metzler-Nolte
Chemical communications 51 (15), 3151-3153, 2015
472015
The X-ray structure of the complex formed in the reaction between oxaliplatin and lysozyme
L Messori, T Marzo, A Merlino
Chemical communications 50 (61), 8360-8362, 2014
462014
The system can't perform the operation now. Try again later.
Articles 1–20